🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/08/2017 | 129,90 | 131,48 | 128,23 | 128,45 | -1,09% | 2,50% | 412.000 |
| 24/08/2017 | 130,69 | 131,00 | 129,11 | 129,86 | -0,66% | 1,45% | 332.400 |
| 23/08/2017 | 130,52 | 131,30 | 129,81 | 130,72 | -0,43% | 1,14% | 332.600 |
| 22/08/2017 | 130,00 | 131,83 | 129,74 | 131,28 | +1,13% | 1,61% | 433.200 |
| 21/08/2017 | 128,57 | 130,96 | 128,40 | 129,81 | +0,55% | 1,99% | 484.800 |
| 18/08/2017 | 130,69 | 131,27 | 128,79 | 129,10 | -1,50% | 1,90% | 557.500 |
| 17/08/2017 | 131,89 | 133,57 | 130,97 | 131,06 | -0,74% | 1,97% | 618.900 |
| 16/08/2017 | 129,67 | 134,10 | 129,53 | 132,04 | +1,76% | 3,52% | 577.100 |
| 15/08/2017 | 129,33 | 131,22 | 128,39 | 129,76 | +0,06% | 2,19% | 449.400 |
| 14/08/2017 | 128,92 | 130,68 | 128,46 | 129,68 | +1,13% | 1,72% | 530.000 |
| 11/08/2017 | 127,40 | 130,48 | 127,40 | 128,23 | +0,95% | 2,42% | 457.300 |
| 10/08/2017 | 128,13 | 128,16 | 126,34 | 127,02 | -1,56% | 1,42% | 711.200 |
| 09/08/2017 | 129,99 | 131,01 | 128,22 | 129,03 | -1,53% | 2,15% | 682.300 |
| 08/08/2017 | 135,23 | 135,38 | 130,69 | 131,04 | -3,26% | 3,47% | 862.000 |
| 07/08/2017 | 137,75 | 137,82 | 133,85 | 135,46 | -0,99% | 2,88% | 787.000 |
| 04/08/2017 | 138,90 | 139,10 | 135,20 | 136,81 | +7,76% | 2,81% | 2.165.600 |
| 03/08/2017 | 127,48 | 128,39 | 125,27 | 126,96 | -0,75% | 2,45% | 449.500 |
| 02/08/2017 | 128,35 | 128,50 | 127,03 | 127,92 | -0,08% | 1,15% | 512.300 |
| 01/08/2017 | 128,51 | 128,91 | 126,04 | 128,02 | -0,30% | 2,23% | 461.400 |
| 31/07/2017 | 127,68 | 129,40 | 127,68 | 128,40 | +0,04% | 1,35% | 390.900 |
| 28/07/2017 | 124,25 | 129,05 | 124,25 | 128,35 | +2,60% | 3,86% | 583.100 |
| 27/07/2017 | 134,01 | 134,33 | 123,05 | 125,10 | -4,79% | 8,42% | 1.430.100 |
| 26/07/2017 | 132,99 | 133,06 | 131,30 | 131,40 | -0,74% | 1,32% | 639.100 |
| 25/07/2017 | 131,66 | 133,61 | 129,22 | 132,38 | +0,68% | 3,33% | 834.600 |
| 24/07/2017 | 130,05 | 132,18 | 129,85 | 131,49 | +1,16% | 1,79% | 378.300 |
| 21/07/2017 | 130,65 | 131,15 | 128,73 | 129,98 | -1,05% | 1,85% | 483.600 |
| 20/07/2017 | 131,55 | 132,45 | 130,83 | 131,36 | +0,08% | 1,23% | 427.600 |
| 19/07/2017 | 130,56 | 132,92 | 130,56 | 131,25 | +0,99% | 1,81% | 416.400 |
| 18/07/2017 | 130,39 | 131,30 | 129,50 | 129,96 | -0,21% | 1,38% | 747.900 |
| 17/07/2017 | 130,98 | 131,61 | 129,73 | 130,24 | -0,29% | 1,44% | 420.500 |